Company Overview
About Opentrons
Opentrons Labworks is a New York-based life sciences company that designs and manufactures affordable, open-source liquid-handling robots for research laboratories. Founded in 2014, Opentrons'' mission is to democratize biology by making advanced lab automation accessible to life scientists at any institution — from academic labs with limited budgets to leading pharmaceutical companies. Its flagship products, the OT-2 and the newer Opentrons Flex, are programmable robotic platforms that automate repetitive liquid-handling tasks such as PCR setup, nucleic acid extraction, ELISA assays, and next-generation sequencing sample preparation.
Business Model & Competitive Advantage
With more than 10,000 robotic systems deployed worldwide, Opentrons has become one of the most widely adopted liquid-handling automation platforms in life sciences. The company has raised over $200 million in total funding, including a $20.1M Series C extension in November 2025. In July 2025, James Atwood was promoted to Chief Executive Officer. Strategic partnerships have accelerated in 2025–2026: BD (Becton, Dickinson) and Opentrons announced a multi-year collaboration in October 2025 to integrate Flex robotic capabilities into BD single-cell multiomics instruments. In February 2026, HighRes and Opentrons announced the industry''s first AI agent-to-agent laboratory automation workflow, connecting autonomous AI agents to physical lab operations.
Competitive Landscape 2025–2026
Opentrons'' open-source software ecosystem and Python-based protocol library allow researchers to write, share, and reuse automation protocols, lowering the barrier to robotic lab adoption. This community-first model drives viral adoption across research institutions. As life science workflows increasingly demand reproducibility, throughput, and AI-driven data generation, Opentrons is positioned at the intersection of lab automation and the emerging lab-of-the-future paradigm, competing with larger incumbents like Hamilton, Tecan, and Beckman Coulter.
Key Differentiators
Market Leader
Opentrons is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare Opentrons with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Opentrons? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Opentrons Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Opentrons vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →